These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37989381)

  • 1. Early 6 months usage of single anTiplAtelet OR anTicoAgulant followed by single antiplatelet after transcatheter aortic valve replacement: protocol for a multicentre, open-label, randomised controlled clinical trial.
    Hu X; Xu H; Wang C; Wang Y; Wang Y; Zhou D; Zhu Q; Xu K; Yang J; Zhang H; Jiang N; Zhang J; Fang Z; Fu G; Guo Y; Li Y; Wang M; Feng D; Niu G; Zhang E; Chen Y; Ye Y; Wu Y
    BMJ Open; 2023 Nov; 13(11):e076781. PubMed ID: 37989381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
    Rodés-Cabau J; Masson JB; Welsh RC; Garcia Del Blanco B; Pelletier M; Webb JG; Al-Qoofi F; Généreux P; Maluenda G; Thoenes M; Paradis JM; Chamandi C; Serra V; Dumont E; Côté M
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1357-1365. PubMed ID: 28527771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement.
    Park H; Kang DY; Ahn JM; Kim KW; Wong AYT; Lam SCC; Yin WH; Wei J; Lee YT; Kao HL; Lin MS; Ko TY; Kim WJ; Kang SH; Ko E; Kim DH; Koo HJ; Yang DH; Kang JW; Jung SC; Lee JH; Yun SC; Park SJ; Park DW
    BMJ Open; 2021 Jan; 11(1):e042587. PubMed ID: 33402409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in Aortic Stenosis: Review of Antiplatelet/Anticoagulant Therapy Management with Transcatheter Aortic Valve Replacement (TAVR): TAVR with Recent PCI, TAVR in the Patient with Atrial Fibrillation, and TAVR Thrombosis Management.
    Sherwood MW; Vora AN
    Curr Cardiol Rep; 2018 Oct; 20(12):130. PubMed ID: 30311013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of dual antiplatelet therapy versus oral anticoagulation following transcatheter aortic valve replacement: A retrospective single-center registry analysis.
    Holy EW; Kebernik J; Allali A; El-Mawardy M; Richardt G; Abdel-Wahab M
    Cardiol J; 2017; 24(6):649-659. PubMed ID: 28497845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex Differences in Outcomes After Transcatheter Aortic Valve Replacement: A POPular TAVI Subanalysis.
    van Bergeijk KH; van Ginkel DJ; Brouwer J; Nijenhuis VJ; van der Werf HW; van den Heuvel AFM; Voors AA; Wykrzykowska JJ; Ten Berg JM
    JACC Cardiovasc Interv; 2023 May; 16(9):1095-1102. PubMed ID: 37164609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic strategies after transcatheter aortic valve implantation: A systematic review and network meta-analysis of randomized controlled trials.
    Ke Y; Wang J; Wang W; Guo S; Dai M; Wu L; Bao Y; Li B; Ju J; Xu H; Jin Y
    Int J Cardiol; 2022 Sep; 362():139-146. PubMed ID: 35654173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
    Windecker S; Tijssen J; Giustino G; Guimarães AH; Mehran R; Valgimigli M; Vranckx P; Welsh RC; Baber U; van Es GA; Wildgoose P; Volkl AA; Zazula A; Thomitzek K; Hemmrich M; Dangas GD
    Am Heart J; 2017 Feb; 184():81-87. PubMed ID: 27892890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet strategy after transcatheter aortic valve replacement: an updated meta-analysis.
    Ma X; Xu Z; Li J; Zhao D; Kong X; Ma J; Ma H; Yun Y; Sun L; Zhang Y; Wei D; Jiao Q; Zou C; Wang Z
    J Cardiovasc Surg (Torino); 2019 Oct; 60(5):624-632. PubMed ID: 31486613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta-analysis.
    Kuno T; Takagi H; Sugiyama T; Ando T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Kanei Y; Hayashida K; Bangalore S
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E177-E186. PubMed ID: 31609071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
    Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
    Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapy with or without clopidogrel after transcatheter aortic valve replacement. A meta-analysis of randomized controlled trials.
    Pellegrini C; Xhepa E; Ndrepepa G; Alvarez-Covarrubias H; Kufner S; Lahmann AL; Rheude T; Rai H; Mayr NP; Schunkert H; Kastrati A; Joner M; Cassese S
    Clin Res Cardiol; 2022 Jan; 111(1):14-22. PubMed ID: 33367949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR: The ADAPT-TAVR Randomized Clinical Trial.
    Park DW; Ahn JM; Kang DY; Kim KW; Koo HJ; Yang DH; Jung SC; Kim B; Wong YTA; Lam CCS; Yin WH; Wei J; Lee YT; Kao HL; Lin MS; Ko TY; Kim WJ; Kang SH; Yun SC; Lee SA; Ko E; Park H; Kim DH; Kang JW; Lee JH; Park SJ;
    Circulation; 2022 Aug; 146(6):466-479. PubMed ID: 35373583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could anticoagulation avoid bioprosthesis subclinical thrombosis in patients undergoing transcatheter aortic valve replacement?
    Huchet F; Letocart V; Guerin P; Cueff C; Roy-Giocosa J; Guyomarch-Delasalle B; Jaafar P; Manigold T
    Arch Cardiovasc Dis; 2018 Jan; 111(1):25-32. PubMed ID: 28943264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin Versus Clopidogrel as Single Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry.
    Kobari Y; Inohara T; Saito T; Yoshijima N; Tanaka M; Tsuruta H; Yashima F; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Yamawaki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Hayashida K
    Circ Cardiovasc Interv; 2021 May; 14(5):e010097. PubMed ID: 34003663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry.
    Kobari Y; Inohara T; Tsuruta H; Yashima F; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Yamawaki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Hayashida K
    JACC Cardiovasc Interv; 2023 Jan; 16(1):79-91. PubMed ID: 36599591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic Therapy After Transcatheter Aortic Valve Replacement.
    Capodanno D; Collet JP; Dangas G; Montalescot G; Ten Berg JM; Windecker S; Angiolillo DJ
    JACC Cardiovasc Interv; 2021 Aug; 14(15):1688-1703. PubMed ID: 34353601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective multicentre open-label randomised controlled trial of 3-month versus 12-month dual antiplatelet therapy after implantation of the new generation biodegradable polymer sirolimus TARGET-eluting coronary stent: protocol of the TARGET DAPT trial.
    Yang H; Zhang F; Yang J; Zheng M; Cao R; Dai Y; Li C; Yao K; Qian J; Ge J;
    BMJ Open; 2019 Dec; 9(12):e033774. PubMed ID: 31852711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin Alone Versus Dual Antiplatelet Therapy After Transcatheter Aortic Valve Implantation: A Systematic Review and Patient-Level Meta-Analysis.
    Brouwer J; Nijenhuis VJ; Rodés-Cabau J; Stabile E; Barbanti M; Costa G; Mahmoodi BK; Ten Berg JM
    J Am Heart Assoc; 2021 Apr; 10(8):e019604. PubMed ID: 33860685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.